+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Blood Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Blood Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 210 Pages
  • January 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 6050328
Description Jump to:
The global Blood Screening Market is poised for significant expansion, driven by technological advancements, rising demand for safe transfusions, and increasing awareness of infectious diseases. According to recent market insights, the industry is expected to witness a CAGR of 8.60%, reaching USD 2.60 billion in 2025 and further surging to USD 4.64 billion by 2032.

Market Insights

Blood screening is a crucial diagnostic procedure designed to detect infectious diseases, monitor health conditions, and ensure the safety of blood transfusions. By analyzing blood components such as antibodies, antigens, and genetic markers, blood screening enables early disease detection and effective medical intervention. The increasing demand for precise diagnostic tools has propelled the growth of this market, with hospitals, blood banks, and laboratories adopting advanced screening technologies to enhance blood safety.

Key Market Drivers

1. Technological Advancements: The development of cutting-edge screening techniques, including Nucleic Acid Testing (NAT), Next-Generation Sequencing (NGS), and point-of-care testing (POCT), has significantly improved diagnostic precision and efficiency.

2. Rising Demand for Blood Transfusions: An increasing number of surgical procedures, trauma cases, and cancer treatments have amplified the need for screened and safe blood supplies.

3. Regulatory Frameworks for Blood Safety: Stringent regulations imposed by health authorities to ensure blood safety are driving the adoption of advanced screening methods.

4. Growing Awareness of Early Disease Detection: With the prevalence of infectious diseases such as HIV, hepatitis, and emerging viral threats, governments and healthcare organizations are emphasizing preventive screening programs.

Business Opportunities

1. Increased Investment in Emerging Markets: The expansion of healthcare infrastructure in developing regions presents lucrative opportunities for market players.

2. Automation in Blood Screening: Adoption of robotics and AI-driven diagnostic solutions is streamlining processes, enhancing accuracy, and reducing turnaround time.

3. Strategic Collaborations: Key players are engaging in mergers, acquisitions, and partnerships to expand their market footprint and develop innovative screening solutions.

4. Personalized Medicine Integration: The increasing focus on precision medicine and genetic screening is anticipated to fuel demand for advanced blood screening technologies.

Regional Analysis

North America: The Market Leader

  • The largest regional market due to advanced healthcare infrastructure and high adoption of innovative screening technologies.
  • Stringent regulatory policies ensure robust blood screening protocols, boosting market growth.
  • Significant R&D investments and presence of major industry players further contribute to market expansion.

South Asia & Pacific: Fastest-Growing Region

  • Increasing incidences of communicable diseases and expanding healthcare accessibility are driving demand.
  • Growing investments in healthcare infrastructure are creating opportunities for advanced blood screening solutions.
  • Rising adoption of POCT and decentralized testing technologies is enhancing market penetration.

Competitive Analysis: Key Players Driving Market Expansion

Prominent companies leading the global blood screening market include:

  • Abbott Laboratories
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd.
  • Grifols, S.A.
  • Ortho-Clinical Diagnostics, Inc.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • SOFINA s.a (Biomerieux)
  • Danaher Corporation (Beckman Coulter)

Market Segmentation

By Technology:

  • Nucleic Acid Amplification Test (NAT)
  • ELISA (Enzyme-Linked Immunosorbent Assay)
  • Chemiluminescence Immunoassay (CLIA) & Enzyme Immunoassay (EIA)
  • Next-Generation Sequencing (NGS)
  • Western Blotting

By Product:

  • Nucleic Acid Amplification Test (NAT) Kits & Reagents
  • ELISA Kits & Instruments
  • Chemiluminescence & Enzyme Immunoassay Products
  • Next-Generation Sequencing Platforms
  • Western Blotting Consumables

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Blood Screening Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. PESTLE Analysis
3. Global Blood Screening Market Outlook, 2019 - 2032
3.1. Global Blood Screening Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
3.1.1. Key Highlights
3.1.1.1. Reagents & Kits
3.1.1.2. Instruments
3.1.1.3. Services
3.2. Global Blood Screening Market Outlook, by Technology, Value (US$ Bn), 2019 - 2032
3.2.1. Key Highlights
3.2.1.1. Nucleic Acid Amplification Test (NAT)
3.2.1.2. ELISA
3.2.1.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
3.2.1.4. Next Generation Sequencing
3.2.1.5. Western Blotting
3.3. Global Blood Screening Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
3.3.1. Key Highlights
3.3.1.1. Blood Banks
3.3.1.2. Hospitals
3.3.1.3. Diagnostic Laboratories
3.3.1.4. Research Institutes
3.3.1.5. Plasma Fractionation Centers
3.4. Global Blood Screening Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Blood Screening Market Outlook, 2019 - 2032
4.1. North America Blood Screening Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
4.1.1. Key Highlights
4.1.1.1. Reagents & Kits
4.1.1.2. Instruments
4.1.1.3. Services
4.2. North America Blood Screening Market Outlook, by Technology, Value (US$ Bn), 2019 - 2032
4.2.1. Key Highlights
4.2.1.1. Nucleic Acid Amplification Test (NAT)
4.2.1.2. ELISA
4.2.1.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
4.2.1.4. Next Generation Sequencing
4.2.1.5. Western Blotting
4.3. North America Blood Screening Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
4.3.1. Key Highlights
4.3.1.1. Blood Banks
4.3.1.2. Hospitals
4.3.1.3. Diagnostic Laboratories
4.3.1.4. Research Institutes
4.3.1.5. Plasma Fractionation Centers
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Blood Screening Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
4.4.1. Key Highlights
4.4.1.1. U.S. Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
4.4.1.2. U.S. Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
4.4.1.3. U.S. Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
4.4.1.4. Canada Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
4.4.1.5. Canada Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
4.4.1.6. Canada Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Blood Screening Market Outlook, 2019 - 2032
5.1. Europe Blood Screening Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Reagents & Kits
5.1.1.2. Instruments
5.1.1.3. Services
5.2. Europe Blood Screening Market Outlook, by Technology, Value (US$ Bn), 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Nucleic Acid Amplification Test (NAT)
5.2.1.2. ELISA
5.2.1.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
5.2.1.4. Next Generation Sequencing
5.2.1.5. Western Blotting
5.3. Europe Blood Screening Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. Blood Banks
5.3.1.2. Hospitals
5.3.1.3. Diagnostic Laboratories
5.3.1.4. Research Institutes
5.3.1.5. Plasma Fractionation Centers
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Blood Screening Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
5.4.1. Key Highlights
5.4.1.1. Germany Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.2. Germany Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
5.4.1.3. Germany Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.4. U.K. Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.5. U.K. Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
5.4.1.6. U.K. Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.7. France Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.8. France Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
5.4.1.9. France Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.10. Italy Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.11. Italy Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
5.4.1.12. Italy Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.13. Turkey Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.14. Turkey Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
5.4.1.15. Turkey Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.16. Russia Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.17. Russia Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
5.4.1.18. Russia Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.19. Rest of Europe Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.20. Rest of Europe Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
5.4.1.21. Rest of Europe Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Blood Screening Market Outlook, 2019 - 2032
6.1. Asia Pacific Blood Screening Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Reagents & Kits
6.1.1.2. Instruments
6.1.1.3. Services
6.2. Asia Pacific Blood Screening Market Outlook, by Technology, Value (US$ Bn), 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Nucleic Acid Amplification Test (NAT)
6.2.1.2. ELISA
6.2.1.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
6.2.1.4. Next Generation Sequencing
6.2.1.5. Western Blotting
6.3. Asia Pacific Blood Screening Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. Blood Banks
6.3.1.2. Hospitals
6.3.1.3. Diagnostic Laboratories
6.3.1.4. Research Institutes
6.3.1.5. Plasma Fractionation Centers
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Blood Screening Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
6.4.1. Key Highlights
6.4.1.1. China Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.2. China Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
6.4.1.3. China Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.4. Japan Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.5. Japan Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
6.4.1.6. Japan Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.7. South Korea Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.8. South Korea Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
6.4.1.9. South Korea Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.10. India Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.11. India Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
6.4.1.12. India Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.13. Southeast Asia Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.14. Southeast Asia Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
6.4.1.15. Southeast Asia Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.16. Rest of Asia Pacific Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.17. Rest of Asia Pacific Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
6.4.1.18. Rest of Asia Pacific Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Blood Screening Market Outlook, 2019 - 2032
7.1. Latin America Blood Screening Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Reagents & Kits
7.1.1.2. Instruments
7.1.1.3. Services
7.2. Latin America Blood Screening Market Outlook, by Technology, Value (US$ Bn), 2019 - 2032
7.2.1.1. Nucleic Acid Amplification Test (NAT)
7.2.1.2. ELISA
7.2.1.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
7.2.1.4. Next Generation Sequencing
7.2.1.5. Western Blotting
7.3. Latin America Blood Screening Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Blood Banks
7.3.1.2. Hospitals
7.3.1.3. Diagnostic Laboratories
7.3.1.4. Research Institutes
7.3.1.5. Plasma Fractionation Centers
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Blood Screening Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
7.4.1. Key Highlights
7.4.1.1. Brazil Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
7.4.1.2. Brazil Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
7.4.1.3. Brazil Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.4. Mexico Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
7.4.1.5. Mexico Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
7.4.1.6. Mexico Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.7. Argentina Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
7.4.1.8. Argentina Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
7.4.1.9. Argentina Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.10. Rest of Latin America Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
7.4.1.11. Rest of Latin America Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
7.4.1.12. Rest of Latin America Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Blood Screening Market Outlook, 2019 - 2032
8.1. Middle East & Africa Blood Screening Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Reagents & Kits
8.1.1.2. Instruments
8.1.1.3. Services
8.2. Middle East & Africa Blood Screening Market Outlook, by Technology, Value (US$ Bn), 2019 - 2032
8.2.1. Key Highlights
8.2.1.1. Nucleic Acid Amplification Test (NAT)
8.2.1.2. ELISA
8.2.1.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
8.2.1.4. Next Generation Sequencing
8.2.1.5. Western Blotting
8.3. Middle East & Africa Blood Screening Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. Blood Banks
8.3.1.2. Hospitals
8.3.1.3. Diagnostic Laboratories
8.3.1.4. Research Institutes
8.3.1.5. Plasma Fractionation Centers
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Blood Screening Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
8.4.1. Key Highlights
8.4.1.1. GCC Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
8.4.1.2. GCC Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
8.4.1.3. GCC Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.4. South Africa Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
8.4.1.5. South Africa Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
8.4.1.6. South Africa Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.7. Egypt Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
8.4.1.8. Egypt Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
8.4.1.9. Egypt Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.10. Nigeria Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
8.4.1.11. Nigeria Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
8.4.1.12. Nigeria Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.13. Rest of Middle East & Africa Blood Screening Market by Product Type, Value (US$ Bn), 2019 - 2032
8.4.1.14. Rest of Middle East & Africa Blood Screening Market by Technology, Value (US$ Bn), 2019 - 2032
8.4.1.15. Rest of Middle East & Africa Blood Screening Market by End User, Value (US$ Bn), 2019 - 2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2025
9.2. Competitive Dashboard
9.3. Company Profiles
9.3.1. Abbott
9.3.1.1. Company Overview
9.3.1.2. Product Portfolio
9.3.1.3. Financial Overview
9.3.1.4. Business Strategies and Development
9.3.2. Becton Dickinson and Company
9.3.2.1. Company Overview
9.3.2.2. Product Portfolio
9.3.2.3. Financial Overview
9.3.2.4. Business Strategies and Development
9.3.3. Bio-Rad Laboratories, Inc.
9.3.3.1. Company Overview
9.3.3.2. Product Portfolio
9.3.3.3. Financial Overview
9.3.3.4. Business Strategies and Development
9.3.4. F.Hoffman-La Roche Ltd.
9.3.4.1. Company Overview
9.3.4.2. Product Portfolio
9.3.4.3. Financial Overview
9.3.4.4. Business Strategies and Development
9.3.5. Grifols, S.A.
9.3.5.1. Company Overview
9.3.5.2. Product Portfolio
9.3.5.3. Financial Overview
9.3.5.4. Business Strategies and Development
9.3.6. Ortho-Clinical Diagnostics, Inc.
9.3.6.1. Company Overview
9.3.6.2. Product Portfolio
9.3.6.3. Financial Overview
9.3.6.4. Business Strategies and Development
9.3.7. Siemens Healthcare GmbH
9.3.7.1. Company Overview
9.3.7.2. Product Portfolio
9.3.7.3. Financial Overview
9.3.7.4. Business Strategies and Development
9.3.8. Thermo Fisher Scientific, Inc.
9.3.8.1. Company Overview
9.3.8.2. Product Portfolio
9.3.8.3. Financial Overview
9.3.8.4. Business Strategies and Development
9.3.9. Others
9.3.9.1. Company Overview
9.3.9.2. Product Portfolio
9.3.9.3. Financial Overview
9.3.9.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Abbott
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Hoffman-La Roche Ltd.
  • Grifols, S.A.
  • Ortho-Clinical Diagnostics, Inc.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • SOFINA s.a (Biomerieux)
  • Danaher Corporation (Beckman Coulter)

Methodology

Loading
LOADING...

Related Topics

Related Reports

Blood Screening Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Blood Screening Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 156 Pages
  • Global
From
Blood Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Blood Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Blood Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Blood Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 187 Pages
  • Global
From
Blood Screening Market by Product & Service, Technology, End-User - Global Forecast 2025-2030 - Product Image

Blood Screening Market by Product & Service, Technology, End-User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Blood Screening Market Size, Share & Trends Analysis Report by Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), Product (Reagent, Instrument), Region, and Segment Forecasts, 2025-2030 - Product Image

Blood Screening Market Size, Share & Trends Analysis Report by Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), Product (Reagent, Instrument), Region, and Segment Forecasts, 2025-2030

  • Report
  • 90 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.